Relapse rate following withdrawal of anti-TNF therapy in patients with inflammatory bowel disease: A single-center experience

被引：0
|
作者：
Sina, M. [1 ]
Pemaj, X. [1 ]
Djegsi, A. [1 ]
Telaku, S. [2 ]
Prifti, S. [1 ]
机构：
[1] Univ Hosp, Internal Med Gastroenterol, Ctr Mother Theresa, Tirana, Albania
[2] UBT, Internal Med Gastroenterol, Pristina, Kosovo
来源：
JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P731
引用
收藏
页码：I1361 / I1361
页数：1
相关论文
共 50 条
  • [1] Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease
    Helwig, Ulf
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2017, 55 (01): : 85 - 85
  • [2] Relapse rate following withdrawal of anti-TNF therapy in patients with inflammatory bowel disease: A real-life cohort from northern India
    Sahu, Pabitra
    Vuyyuru, Sudheer K.
    Kante, Bhaskar
    Agarwal, Ashish
    Sharma, Raju
    Das, Prasenjit
    Panwar, Rajesh
    Jain, Saransh
    Bopanna, Sawan
    Makharia, Govind
    Kedia, Saurabh
    Ahuja, Vineet
    [J]. INDIAN JOURNAL OF GASTROENTEROLOGY, 2020, 39 (04) : 388 - 397
  • [3] Relapse rate following withdrawal of anti-TNF therapy in patients with inflammatory bowel disease: A real-life cohort from northern India
    Pabitra Sahu
    Sudheer K. Vuyyuru
    Bhaskar Kante
    Ashish Agarwal
    Raju Sharma
    Prasenjit Das
    Rajesh Panwar
    Saransh Jain
    Sawan Bopanna
    Govind Makharia
    Saurabh Kedia
    Vineet Ahuja
    [J]. Indian Journal of Gastroenterology, 2020, 39 : 388 - 397
  • [4] OUTCOMES FOLLOWING ANTI-TNF DISCONTINUATION AND THE RISK OF RELAPSE IN INFLAMMATORY BOWEL DISEASE; A SINGLE CENTRE EXPERIENCE
    Coffey, L.
    Mullen, A.
    Leyden, J.
    MacMathuna, P.
    [J]. GUT, 2017, 66 : A2 - A2
  • [5] Need for anti-TNF escalation in Inflammatory Bowel Disease - A single center experience
    Fernandes, S.
    Moura, C.
    Santos, P.
    Sousa, P.
    Correia, L.
    Moura Santos, P.
    Valente, A.
    Rita Goncalves, A.
    Baldaia, C.
    Fatela, N.
    Serejo, F.
    Velosa, J.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S336 - S337
  • [6] Anti-TNF Withdrawal in Inflammatory Bowel Disease With Endoscopic Healing and the Risk of Relapse - Reply
    Mahmoud, Remi
    Savelkoul, Edo H. J.
    Jharap, Bindia
    Oldenburg, Bas
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (07) : 1967 - 1968
  • [7] Predictors of Anti-TNF Therapy Failure among Inflammatory Bowel Disease (IBD) Patients in Saudi Arabia: A Single-Center Study
    Alharbi, Othman
    Aljebreen, Abdulrahman M.
    Azzam, Nahla A.
    Almadi, Majid A.
    Saeed, Maria
    HajkhderMullaissa, Baraa
    Asiri, Hassan
    Almutairi, Abdullah
    AlRuthia, Yazed
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (14)
  • [8] Optimization of anti-TNF therapy in patients with Inflammatory Bowel Disease
    Strik, A. S.
    Bots, S. J. A.
    D'Haens, G.
    Lowenberg, M.
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (03) : 429 - 439
  • [9] The association of psoriasis with anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease: A single-center case series
    Afzali, Anita
    Wheat, Chelle
    Lee, Scott
    [J]. INFLAMMATORY BOWEL DISEASES, 2011, 17 : S17 - S17
  • [10] Biosimilar Infliximab Is Effective and Safe in Inflammatory Bowel Disease Patients Naive to Anti-TNF Therapy: A Tertiary Center Experience
    Bortlik, Martin
    Kolar, Martin
    Duricova, Dana
    Malickova, Karin
    Hruba, Veronika
    Machkova, Nadezda
    Mitrova, Katarina
    Lukas, Martin
    Lukas, Milan
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S106 - S106
12345